![]() | Joel A BlockRush University Medical Center, Chicago, IL | Division of Rheumatology, Rush University Medical Center, Chicago, IL, USA | Department of Internal Medicine, Division of ... |
KOL Resume for Joel A Block
Year | |
---|---|
2022 | Rush University Medical Center, Chicago, IL |
2021 | Department of Internal Medicine, Division of Rheumatology, Rush Medical College, Chicago, IL, United States of America Division of Rheumatology, Rush Medical College, Chicago, Illinois. |
2020 | Division of Rheumatology, Rush University Medical Center, 1611 W Harrison Street, Suite 510, Chicago, IL 60612, United States of America. Electronic address: Rush University Medical Center, Chicago, Illinois |
2019 | Rush Univ. Med. Ctr., Chicago, IL, USA From the Division of Rheumatology. |
2018 | Division of Rheumatology, Rush University Medical CenterChicago, USA. |
2017 | From the *Cook County Health & Hospital Systems; †Midwest Orthopedics Rush University Medical Center; ‡Division of Rheumatology, Rush University Medical Center; §Division of, Rush University, Chicago, IL. RUSH Univ. Med. Ctr., Chicago, IL, USA Rheumatology, Rush University Medical Center, Chicago, United States |
2016 | Division of Rheumatology, Rush University Medical Center, Chicago, IL, USA. Rush Medical College, Department of Internal Medicine, Section of Rheumatology, Department of Biochemistry, Chicago, IL, USA |
2015 | Rush University Medical Center, Chicago, IL and, Cook County Health and Hospital Systems, IL. |
2014 | Rush University Medical Center, Section of Rheumatology, Chicago, IL, USA |
2013 | Rush University Medical Center, Chicago, IL USA |
2012 | Section of Rheumatology, Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois Rush University, Chicago, IL |
2011 | Department of Medicine, Rush University Medical Center, 1611 West Harrison Street, Suite 510, 60612, Chicago, IL, USA Dept. of Medicine, Rush University Medical Center, Chicago, IL 60612, United States |
2010 | Section of Rheumatology, Rush University Medical Center, 1611 W. Harrison St, Suite 510, 60612, Chicago, IL, USA |
2009 | Section of Rheumatology, Rush Medical College, Rush University Medical Center, 1725 W. Harrison Street, Suite 1017, 60612, Chicago, IL, USA |
2008 | Section of Rheumatology, John H. Stroger Hospital of Cook County; and Rush University Medical Center, Chicago, IL. Rush University Medical Center, Chicago, IL, United States |
2007 | Section of Rheumatology, Rush University Medical Center, 1725 West Harrison Street, Suite 1017, Chicago, IL 60612 |
2006 | Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois |
2005 | Section of Rheumatology, Department of Internal Medicine, Rush Medical College, Rush University Medical Center, Chicago, IL, USA Department of Rheumatology, Rush Medical College, Rush University Medical Center, 1725 W. Harrison Street, Suite 1017, Chicago, IL 60612 |
2004 | Section of Rheumatology, Rush Medical College, Rush-Presbyterian–St. Luke’s Medical Center, Chicago, Illinois. Rheumatology, Rush University Medical Center, Chicago, IL, USA |
2003 | Rush Medical College, Chicago, IL, USA |
2002 | Department of Internal Medicine, Section of Rheumatology, Rush Medical College of Rush University, Rush-Presbyterian-St Luke's Medical Center, Chicago, Illinois, U.S.A. Section of Rheumatology, Rush Medical College, IL 60612, Chicago, USA Rush–Presbyterian–St. Luke's Medical Center, Chicago, Illinois |
Joel A Block: Influence Statistics
Concept | World rank |
---|---|
barefoot decreases | #1 |
visible jsw | #1 |
pglycoprotein doxorubicin | #1 |
hip radiographic parameters | #1 |
lupusqolus hrqol | #1 |
lupuspro test | #1 |
methods ttp | #1 |
turkish translated version | #1 |
lubricin kda | #1 |
szp abundant glycoprotein | #1 |
selenasledai simple | #1 |
routine crosssectional study | #1 |
doxorubicin aq cell | #1 |
patgldocgl≤ − | #1 |
clasi disease activity | #1 |
105kc kc2h3 | #1 |
kc2h3 cultured chondroitin | #1 |
asymptomatic donors patients | #1 |
endogenous fak activity | #1 |
docgl patients | #1 |
tailored weekly intervention | #1 |
ttp systemic sclerosis | #1 |
willebrand cleaving protease | #1 |
monoclonal antibody c494 | #1 |
assessment patgl | #1 |
mail dropback lupuspro | #1 |
leg length jsw | #1 |
knee chosen | #1 |
illness software lit | #1 |
impulse subjects | #1 |
differences comp | #1 |
sliccacr sle damage | #1 |
angular momentum time | #1 |
ethnicity lupusqol | #1 |
retest analysis test | #1 |
physicians sle patients | #1 |
hypoxia neovascularity | #1 |
maintenance disorders lupuspro | #1 |
asymmetric loading persists | #1 |
progression joint degeneration | #1 |
stance explained | #1 |
participants pressure sensors | #1 |
sdi assessed | #1 |
simple selenasledai | #1 |
narrowing jsw | #1 |
filipino sle patients | #1 |
literature‐related discovery | #1 |
assessment simple | #1 |
active etanercept therapy | #1 |
heterogeneity hydrodynamic size | #1 |
Open the FULL List in Excel | |
Prominent publications by Joel A Block
Based on the premise that bone mass and bone geometry are related to load history and that subchondral bone may play a role in osteoarthritis (OA), we sought to determine if static and dynamic markers of knee joint loads explain variance in the medial-to-lateral ratio of proximal tibial bone mineral density (BMD) in subjects with mild and moderate medial knee OA. We utilized two surrogate markers of dynamic load, the peak knee adduction moment and the knee adduction angular momentum, the ...
Known for Knee Adduction | Proximal Tibia | Bone Mineral Density | Bmd Ratio | Static Alignment |
Increased knee joint loads during walking are present in subjects with knee osteoarthritis
[ PUBLICATION ]
OBJECTIVE: This study tests the hypothesis that the peak external knee adduction moment during gait is increased in a group of ambulatory subjects with knee osteoarthritis (OA) of varying radiographic severity who are being managed with medical therapy. Tibiofemoral knee OA more commonly affects the medial compartment. The external knee adduction moment can be used to assess the load distribution between the medial and lateral compartments of the knee joint. Additionally, this study ...
Known for Subjects Knee | Medial Compartment | Moment Gait | Load Distribution | Aged Osteoarthritis |
Cross-cultural Validation of a Disease-specific Patient-reported Outcome Measure for Systemic Lupus Erythematosus in Canada
[ PUBLICATION ]
OBJECTIVE: The LupusPRO, a disease-targeted patient-reported outcome measure, was developed and validated in US patients with systemic lupus erythematosus (SLE). We report the results of the cross-cultural validation study of the English version of the LupusPRO among patients in Canada with SLE.
METHOD: The LupusPRO was administered to English-speaking Canadian patients with SLE. Demographic, clinical, and serological characteristics were obtained, and the Medical Outcomes Study Short ...
Known for Systemic Lupus Erythematosus | Sle Lupuspro | Criterion Validity | Reported Outcome | Cultural Validation |
Excessive release of basic fibroblast growth factor (bFGF) during loading and/or injury of the cartilage matrix may contribute to the onset or progression of osteoarthritis. This pathological role may be related to the ability of bFGF to decrease proteoglycan synthesis and to antagonize the activity of anabolic growth factors in cartilage such as insulin-like growth factor-1 and bone morphogenetic protein 7 (BMP7 or OP-1). Matrix metalloproteinase-13 (MMP-13), a catabolic ...
Known for Matrix Metalloproteinase | Growth Factor | Protein Kinase | Articular Chondrocytes | Human Adult |
This study tested whether the peak external knee adduction moments during walking in subjects with knee osteoarthritis (OA) were correlated with the mechanical axis of the leg, radiographic measures of OA severity, toe out angle or clinical assessments of pain, stiffness or function. Gait analysis was performed on 62 subjects with knee OA and 49 asymptomatic control subjects (normal subjects). The subjects with OA walked with a greater than normal peak adduction moment during early ...
Known for Knee Osteoarthritis | Static Alignment | Mechanical Axis | Peak Adduction | Radiographic Measures |
OBJECTIVE: Subjects with unilateral end-stage hip osteoarthritis (OA) who undergo total hip replacement (THR) preferentially require subsequent replacement of the contralateral knee compared with the ipsilateral knee. We investigated whether this nonrandom, preferential evolution of lower extremity OA from the hip to the contralateral knee joint may be related to asymmetries in dynamic joint loading at the knees, particularly the peak external knee adduction moment, which has been ...
Known for Hip Osteoarthritis | Contralateral Knee | Unilateral Thr | Gait Analysis | Lower Extremity |
OBJECTIVE: The rate of progressive joint space narrowing in the contralateral hip after total hip arthroplasty (THA) for osteoarthritis (OA) and the factors which may predispose patients to more aggressive joint space narrowing remain undefined. The current study sought to evaluate the rate and pattern of, and risk factors for, progressive joint space narrowing in the contralateral hip after THA for OA.
METHODS: Each patient who underwent THA for OA in 1984-1985 was followed up ...
Known for Contralateral Hip | Joint Space | Jsw Tha | Weight Height | Aged Osteoarthritis |
Serum free light chains as biomarkers for systemic lupus erythematosus disease activity
[ PUBLICATION ]
OBJECTIVE: To evaluate serum free light chains (FLC) as a putative biomarker of systemic lupus erythematosus (SLE) activity.
METHODS: Seventy-five SLE patients and 41 age- and sex-matched rheumatoid arthritis (RA) controls were enrolled. Disease activity was assessed using the Safety of Estrogens in Lupus Erythematosus: National Assessment version of the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) definition and physician global assessments for SLE and the Disease ...
Known for Lupus Erythematosus | Light Chains | Disease Activity Sle | Serum Free | Renal Function |
Although treatments for osteoarthritis of the knee are often directed at relieving pain, pain may cause patients to alter how they perform activities to decrease the loads on the joints. The knee-adduction moment is a major determinant of the load distribution between the medial and lateral plateaus. Therefore, the interrelationship between pain and the external knee-adduction moment during walking may be especially important for understanding mechanical factors related to the ...
Known for Knee Pain | Joint Loading | Adduction Moment | Peak External | Aged Osteoarthritis |
OBJECTIVE: To evaluate the continued efficacy and safety of alendronate (ALN) for up to 2 years in patients receiving glucocorticoids.
METHODS: This is a 12-month extension of a previously completed 1-year trial of daily ALN, performed to evaluate the effects of ALN over a total of 2 years in 66 men and 142 women continuing to receive at least 7.5 mg of prednisone or equivalent daily. All patients received supplemental calcium and vitamin D. The primary end point was the mean percentage ...
Known for Vertebral Fracture | Aln Bmd | Receiving Glucocorticoids | 2 Years | Bone Mineral |
The radiographic joint space width in clinically normal hips: effects of age, gender and physical parameters
[ PUBLICATION ]
OBJECTIVE: The aim of the study was to assess the relationship of the radiographic joint space width (JSW) in the hip with age and a variety of physical parameters in a clinically non-arthritic population in order to identify potential age-related changes.
DESIGN: One hundred and eighteen patients (58F/60M, age range 20-79 years) who underwent supine abdominal radiography for non-rheumatological indications and had no hip pain were evaluated. Height, weight and leg lengths were measured. ...
Known for Jsw Hip | Physical Parameters | Radiographic Joint | Height Weight | Space Width |
The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis
[ PUBLICATION ]
Nonsteroidal anti-inflammatory drugs. (NSAIDs) inhibit both cyclooxygenase (COX)-1 and COX-2 isoenzymes and are effective in the treatment of inflammatory disorders. This 8-week, double-masked, placebo-controlled trial was undertaken to assess the safety profile, tolerability, and effective dose range of once-daily rofecoxib, a COX-2-specific inhibitor, in the treatment of rheumatoid arthritis (RA). After a 3- to 15-day washout of prior NSAID therapy, 658 patients were randomly allocated ...
Known for Safety Profile | Rheumatoid Arthritis | Patients Rofecoxib | 25 50 | Cyclooxygenase Inhibitors |
Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus.
[ PUBLICATION ]
OBJECTIVE: Health related quality of life (HRQOL) is an important patient-reported outcome in systemic lupus erythematosus (SLE). We evaluated the psychometric properties of 2 widely used preference-based generic HRQOL measures, EuroQol-5D (EQ-5D) and Short Form-6D (SF-6D), among United States patients with SLE.
METHODS: Patients with SLE enrolled at an academic institution were assessed for self-reported generic HRQOL (EQ-5D, Medical Outcomes Study SF-36), disease activity, and disease ...
Known for Psychometric Properties | Patients Sle | Lupus Erythematosus | Sf6d Eq5d | Life Hrqol |
Key People For Rheumatoid Arthritis
Joel A Block:Expert Impact
Concepts for whichJoel A Blockhas direct influence:Rheumatoid arthritis, Systemic lupus erythematosus, Lupus erythematosus, Knee osteoarthritis, Rheumatic diseases, Muscle strength, Chondrosarcoma cells, Systemic lupus.
Joel A Block:KOL impact
Concepts related to the work of other authors for whichfor which Joel A Block has influence:Knee osteoarthritis, Rheumatoid arthritis, Articular cartilage, Systemic lupus erythematosus, Adduction moment, Synovial fluid, Rheumatic diseases.
Tools
Is this your profile? Claim your profile Copy URL Embed Link to your profile |